Cite
HARVARD Citation
Peterse, E. et al. (2016). No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone. BMC cancer. 16 (1), pp. 1-11. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Peterse, E. et al. (2016). No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone. BMC cancer. 16 (1), pp. 1-11. [Online].